FDA label
What is Multaq used for?
Multaq contains dronedarone. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “MULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Multaq?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Multaq, tablet, film coated
Indications and Usage, quoted from the label by Sanofi-Aventis U.S. LLC (NDA022425). Cross-references to other label sections are left out.
MULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF).
Source: DailyMed label, set id 7fa41601-7fb5-4155-8e50-2ae903f0d2d6, version 37, effective May 29, 2025. NDC 0024-4142, one of 2 listings for this product.
Questions
What is Multaq used for?
The FDA label says: “MULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF).”
What drug class is Multaq?
FDA lists dronedarone in the Antiarrhythmic established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.